ArticleOncotarget2014

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.

Laura Gatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.